{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:07:02Z","timestamp":1776467222881,"version":"3.51.2"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bioactmat.2024.08.047","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:34:12Z","timestamp":1726612452000},"page":"67-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Immune-modulative nano-gel-nano system for patient-favorable cancer therapy"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9954-7430","authenticated-orcid":false,"given":"Sung Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0123-877X","authenticated-orcid":false,"given":"Rafael T.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-1485","authenticated-orcid":false,"given":"Hyung-Seop","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0912-3010","authenticated-orcid":false,"given":"Young-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7378","key":"10.1016\/j.bioactmat.2024.08.047_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"issue":"36","key":"10.1016\/j.bioactmat.2024.08.047_bib2","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1200\/JCO.2011.38.0899","article-title":"Cancer immunotherapy comes of age","volume":"29","author":"Topalian","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.08.047_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","article-title":"Combination cancer immunotherapies tailored to the tumour microenvironment","volume":"13","author":"Smyth","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.08.047_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.08.047_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2024.08.047_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2017.05.011","article-title":"Delivering safer immunotherapies for cancer","volume":"114","author":"Milling","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6382","key":"10.1016\/j.bioactmat.2024.08.047_bib7","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.08.047_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cell.2017.08.031","article-title":"Converting cold into hot tumors by combining immunotherapies","volume":"170","author":"Haanen","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bioactmat.2024.08.047_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (time) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2024.08.047_bib10","first-page":"1","article-title":"Challenges in developing personalized neoantigen cancer vaccines","author":"Katsikis","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.08.047_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.08.047_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.08.047_bib13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri1150","article-title":"Cancer vaccines: between the idea and the reality","volume":"3","author":"Finn","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2024.08.047_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.03.034","article-title":"Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity","volume":"130","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.08.047_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.11.024","article-title":"Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy","volume":"44","author":"Pfirschke","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.08.047_bib16","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/s41467-020-19540-z","article-title":"Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.08.047_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrclinonc.2010.223","article-title":"Immune parameters affecting the efficacy of chemotherapeutic regimens","volume":"8","author":"Zitvogel","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.08.047_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"42","key":"10.1016\/j.bioactmat.2024.08.047_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903242","article-title":"A designer scaffold with immune nanoconverters for reverting immunosuppression and enhancing immune checkpoint blockade therapy","volume":"31","author":"Phuengkham","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.08.047_bib20","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1245\/s10434-008-0037-5","article-title":"Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery","volume":"15","author":"Smith","year":"2008","journal-title":"Ann. Surg Oncol."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.08.047_bib21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/SLA.0b013e3181efc635","article-title":"Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung","volume":"252","author":"Al-Sahaf","year":"2010","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bioactmat.2024.08.047_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2014.03.054","article-title":"Controlled drug delivery systems: past forward and future back","volume":"190","author":"Park","year":"2014","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.08.047_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.08.047_bib24","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1021\/acsnano.0c02765","article-title":"Co-delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccines","volume":"14","author":"Shae","year":"2020","journal-title":"ACS Nano"},{"issue":"27","key":"10.1016\/j.bioactmat.2024.08.047_bib25","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1016\/j.biomaterials.2014.05.070","article-title":"Targetable micelleplex hydrogel for long-term, effective, and systemic sirna delivery","volume":"35","author":"Kim","year":"2014","journal-title":"Biomaterials"},{"issue":"22","key":"10.1016\/j.bioactmat.2024.08.047_bib26","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1021\/ma00126a039","article-title":"Synthesis and properties of low molecular weight polyphosphazenes","volume":"28","author":"Sohn","year":"1995","journal-title":"Macromolecules"},{"key":"10.1016\/j.bioactmat.2024.08.047_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.eurpolymj.2016.11.029","article-title":"A facile amino-functionalization of poly (2-oxazoline) s\u2019 distal end through sequential azido end-capping and staudinger reactions","volume":"88","author":"Osawa","year":"2017","journal-title":"Eur. Polym. J."},{"issue":"31","key":"10.1016\/j.bioactmat.2024.08.047_bib28","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1016\/j.biomaterials.2009.08.011","article-title":"The use of injectable, thermosensitive poly (organophosphazene)\u2013rgd conjugates for the enhancement of mesenchymal stem cell osteogenic differentiation","volume":"30","author":"Chun","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.08.047_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.actbio.2022.03.033","article-title":"Long-term anti-inflammatory effects of injectable celecoxib nanoparticle hydrogels for achilles tendon regeneration","volume":"144","author":"Kim","year":"2022","journal-title":"Acta Biomater."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.08.047_bib30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/bm100197y","article-title":"Dual cross-linking systems of functionally photo-cross-linkable and thermoresponsive polyphosphazene hydrogels for biomedical applications","volume":"11","author":"Potta","year":"2010","journal-title":"Biomacromolecules"},{"issue":"24","key":"10.1016\/j.bioactmat.2024.08.047_bib31","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/marc.201000350","article-title":"Rapid photocrosslinkable thermoresponsive injectable polyphosphazene hydrogels","volume":"31","author":"Potta","year":"2010","journal-title":"Macromol. Rapid Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.08.047_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100246","article-title":"Preparation and culture of bone marrow-derived macrophages from mice for functional analysis","volume":"2","author":"Toda","year":"2021","journal-title":"STAR protocols"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.08.047_bib33","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.immuni.2015.05.018","article-title":"Gm-csf mouse bone marrow cultures comprise a heterogeneous population of cd11c+ mhcii+ macrophages and dendritic cells","volume":"42","author":"Helft","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.08.047_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41467-017-00583-8","article-title":"An injectable hydrogel enhances tissue repair after spinal cord injury by promoting extracellular matrix remodeling","volume":"8","author":"Hong","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bioactmat.2024.08.047_bib35","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1021\/ma0305838","article-title":"Synthesis and characterization of biodegradable thermosensitive poly (organophosphazene) gels","volume":"37","author":"Lee","year":"2004","journal-title":"Macromolecules"},{"issue":"7","key":"10.1016\/j.bioactmat.2024.08.047_bib36","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/nn300842a","article-title":"Injectable polyplex hydrogel for localized and long-term delivery of sirna","volume":"6","author":"Kim","year":"2012","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.08.047_bib37","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1021\/ma012093q","article-title":"A thermosensitive poly (organophosphazene) gel","volume":"35","author":"Lee","year":"2002","journal-title":"Macromolecules"},{"key":"10.1016\/j.bioactmat.2024.08.047_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.04.023","article-title":"Sustained bmp-2 delivery and injectable bone regeneration using thermosensitive polymeric nanoparticle hydrogel bearing dual interactions with bmp-2","volume":"209","author":"Seo","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.08.047_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2016.08.015","article-title":"Thermosensitive\/superparamagnetic iron oxide nanoparticle-loaded nanocapsule hydrogels for multiple cancer hyperthermia","volume":"106","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.08.047_bib40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12272-013-0013-x","article-title":"Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts","volume":"36","author":"Kim","year":"2013","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.08.047_bib41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/acsmacrolett.6b00008","article-title":"Injectable ternary nanocomplex hydrogel for long-term chemical drug\/gene dual delivery","volume":"5","author":"Kim","year":"2016","journal-title":"ACS Macro Lett."},{"issue":"43","key":"10.1016\/j.bioactmat.2024.08.047_bib42","doi-asserted-by":"crossref","first-page":"42604","DOI":"10.1074\/jbc.M303303200","article-title":"A novel rgd-independent cell adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis","volume":"278","author":"Verderio","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.08.047_bib43","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1021\/la504378m","article-title":"Nile red dye in aqueous surfactant and micellar solution","volume":"31","author":"Kurniasih","year":"2015","journal-title":"Langmuir"},{"issue":"12","key":"10.1016\/j.bioactmat.2024.08.047_bib44","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1080\/21645515.2021.1964316","article-title":"Using pamps and damps as adjuvants in cancer vaccines","volume":"17","author":"Sun","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"issue":"41","key":"10.1016\/j.bioactmat.2024.08.047_bib45","doi-asserted-by":"crossref","first-page":"17218","DOI":"10.1039\/D1NR05512G","article-title":"Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo-immunotherapy","volume":"13","author":"Jiang","year":"2021","journal-title":"Nanoscale"},{"issue":"22","key":"10.1016\/j.bioactmat.2024.08.047_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201734","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.08.047_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01297-0","article-title":"Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma","volume":"20","author":"Guo","year":"2021","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.08.047_bib48","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/2326-6066.CIR-19-0616","article-title":"Paclitaxel induces immunogenic cell death in ovarian cancer via tlr4\/ikk2\/snare-dependent exocytosis","volume":"8","author":"Lau","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.08.047_bib49","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1038\/s41598-019-45542-z","article-title":"Boiling histotripsy-induced partial mechanical ablation modulates tumour microenvironment by promoting immunogenic cell death of cancers","volume":"9","author":"Pahk","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.08.047_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","article-title":"Calreticulin and cancer","volume":"31","author":"Fucikova","year":"2021","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.08.047_bib51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.08.047_bib52","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153086","article-title":"Alterations in mitochondrial morphology as a key driver of immunity and host defence","volume":"22","author":"Cervantes-Silva","year":"2021","journal-title":"EMBO Rep."},{"issue":"39","key":"10.1016\/j.bioactmat.2024.08.047_bib53","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1073\/pnas.0603493103","article-title":"Activation of nf-\u03bab by the intracellular expression of nf-\u03bab-inducing kinase acts as a powerful vaccine adjuvant","volume":"103","author":"Andreakos","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.08.047_bib54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/cells10020355","article-title":"Nf-\u03bab in cancer immunity: friend or foe?","volume":"10","author":"Lalle","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.bioactmat.2024.08.047_bib55","doi-asserted-by":"crossref","first-page":"12671","DOI":"10.1021\/acsnano.9b04207","article-title":"Lyophilizable and multifaceted toll-like receptor 7\/8 agonist-loaded nanoemulsion for the reprogramming of tumor microenvironments and enhanced cancer immunotherapy","volume":"13","author":"Kim","year":"2019","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.08.047_bib56","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"Tlr7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"19","key":"10.1016\/j.bioactmat.2024.08.047_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201808303","article-title":"Tailoring nanomaterials for targeting tumor-associated macrophages","volume":"31","author":"Ovais","year":"2019","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.bioactmat.2024.08.047_bib58","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-17-3480","article-title":"Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an m1 profile in a tlr4-dependent manner","volume":"78","author":"Wanderley","year":"2018","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.08.047_bib59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the t cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.08.047_bib60","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"Cpg motifs in bacterial dna and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"13","key":"10.1016\/j.bioactmat.2024.08.047_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103689","article-title":"Immunotherapy of malignant glioma by noninvasive administration of tlr9 agonist cpg nano-immunoadjuvant","volume":"9","author":"Wei","year":"2022","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.08.047_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202211423","article-title":"Ni-alginate hydrogel microspheres with sustained interleukin 2 release to boost cytokine-based cancer immunotherapy","volume":"33","author":"Xiong","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"12","key":"10.1016\/j.bioactmat.2024.08.047_bib63","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1021\/acsnano.8b05292","article-title":"Cell-membrane immunotherapy based on natural killer cell membrane coated nanoparticles for the effective inhibition of primary and abscopal tumor growth","volume":"12","author":"Deng","year":"2018","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.bioactmat.2024.08.047_bib64","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.7150\/thno.25613","article-title":"Distinct immune signatures in directly treated and distant tumors result from tlr adjuvants and focal ablation","volume":"8","author":"Chavez","year":"2018","journal-title":"Theranostics"},{"issue":"433","key":"10.1016\/j.bioactmat.2024.08.047_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar1916","article-title":"Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases","volume":"10","author":"Park","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.08.047_bib66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.bioactmat.2024.08.047_bib67","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1158\/1078-0432.CCR-07-0517","article-title":"Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth","volume":"13","author":"Zhong","year":"2007","journal-title":"Clin. Cancer Res."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24003852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24003852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T04:29:39Z","timestamp":1733718579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X24003852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":67,"alternative-id":["S2452199X24003852"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.08.047","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-modulative nano-gel-nano system for patient-favorable cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}